Dai-ichi Life Insurance Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.74M Sell
94,663
-24,302
-20% -$1.42M 0.16% 133
2025
Q4
$6.42M Hold
118,965
0.17% 125
2025
Q3
$5.37M Buy
118,965
+5,068
+4% +$237K 0.13% 154
2025
Q2
$5.27M Buy
113,897
+40,712
+56% +$2M 0.15% 145
2025
Q1
$4.46M Hold
73,185
0.13% 165
2024
Q4
$4.14M Buy
73,185
+6,988
+11% +$390K 0.11% 183
2024
Q3
$3.43M Buy
66,197
+50,000
+309% +$2.35M 0.09% 206
2024
Q2
$673K Sell
16,197
-15,055
-48% -$674K 0.02% 404
2024
Q1
$1.69M Sell
31,252
-7,331
-19% -$373K 0.04% 319
2023
Q4
$1.98M Sell
38,583
-345,538
-90% -$18.1M 0.04% 303
2023
Q3
$22.3M Sell
384,121
-64,029
-14% -$3.92M 0.49% 41
2023
Q2
$28.7M Sell
448,150
-26,477
-6% -$1.78M 0.6% 34
2023
Q1
$32.9M Buy
474,627
+23,472
+5% +$1.66M 0.72% 19
2022
Q4
$32.5M Buy
451,155
+112,346
+33% +$8.47M 0.75% 24
2022
Q3
$24.1M Buy
338,809
+5,364
+2% +$389K 0.59% 32
2022
Q2
$25.7M Buy
333,445
+71,464
+27% +$5.44M 0.57% 34
2022
Q1
$19.1M Buy
261,981
+51,603
+25% +$3.46M 0.31% 76
2021
Q4
$13.1M Sell
210,378
-27,551
-12% -$1.62M 0.17% 116
2021
Q3
$14.1M Sell
237,929
-27,011
-10% -$1.78M 0.18% 105
2021
Q2
$17.7M Buy
264,940
+22,160
+9% +$1.44M 0.22% 89
2021
Q1
$15.3M Sell
242,780
-9,584
-4% -$596K 0.21% 85
2020
Q4
$15.7M Buy
252,364
+9,364
+4% +$576K 0.23% 77
2020
Q3
$14.7M Buy
243,000
+24,328
+11% +$1.46M 0.26% 70
2020
Q2
$12.9M Sell
218,672
-2,885
-1% -$173K 0.29% 65
2020
Q1
$12.3M Sell
221,557
-49,852
-18% -$3.05M 0.47% 51
2019
Q4
$17.4M Buy
271,409
+93,744
+53% +$5.37M 0.39% 62
2019
Q3
$9.01M Buy
177,665
+2,110
+1% +$99.2K 0.22% 107
2019
Q2
$7.96M Sell
175,555
-252,549
-59% -$11.8M 0.19% 123
2019
Q1
$20.4M Buy
428,104
+221,679
+107% +$11M 0.5% 43
2018
Q4
$10.7M Sell
206,425
-10,820
-5% -$581K 0.29% 88
2018
Q3
$13.5M Sell
217,245
-2,687
-1% -$159K 0.29% 84
2018
Q2
$12.2M Sell
219,932
-20,247
-8% -$1.09M 0.29% 82
2018
Q1
$15.2M Sell
240,179
-8,279
-3% -$533K 0.31% 70
2017
Q4
$15.2M Sell
248,458
-3,689
-1% -$231K 0.3% 66
2017
Q3
$16.1M Sell
252,147
-775
-0.3% -$45.3K 0.34% 57
2017
Q2
$14.1M Sell
252,922
-59,286
-19% -$3.23M 0.31% 62
2017
Q1
$17M Buy
312,208
+14,542
+5% +$798K 0.46% 41
2016
Q4
$17.4M Buy
+297,666
New +$16.3M 0.52% 40

Other funds holding BMY

Dai-ichi Life Insurance Company's BMY Position: Q1 2026 in Review

Dai-ichi Life Insurance Company reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, selling an estimated $1.42M and leaving 94,663 shares worth $5.74M. The position accounts for 0.16% of the portfolio, ranked #133.

Dai-ichi Life Insurance Company first reported a position in BMY in Q4 2016 and has held it in 38 quarters since. The position peaked at $32.9M in Q1 2023. 2,524 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Dai-ichi Life Insurance Company held 94,663 shares of Bristol-Myers Squibb worth $5.74M as of Q1 2026.
  • Dai-ichi Life Insurance Company sold 24,302 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.42M.
  • Bristol-Myers Squibb made up 0.16% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #133 holding.
  • Dai-ichi Life Insurance Company first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 38 quarters since.
  • Dai-ichi Life Insurance Company's Bristol-Myers Squibb position peaked at $32.9M in Q1 2023.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.